Regulators remove restrictions on Aetna's Medicare sales

NewsGuard 100/100 Score

The sanctions had blocked Aetna Inc. from marketing Medicare plans and enrolling new beneficiaries. Now that they have been lifted, Aetna has indicated it will again promote its Medicare Advantage offerings.

The Wall Street Journal: Aetna Says U.S. Regulators Lift Sanctions Blocking Medicare Sales
The removal of the restriction imposed by the Centers for Medicare and Medicaid Services last April is important as Aetna, like other carriers, seeks to bulk up its presence in the Medicare category. Aetna said it will immediately resume promoting its offerings under Medicare Advantage, the private-plan version of the program that covers the elderly and disabled, and the prescription drug benefit. The company will begin enrolling new beneficiaries with effective dates beginning July 1. Aetna currently has around one million Medicare Advantage and drug-plan beneficiaries, and will now be able to compete for new ones during Medicare's autumn open-enrollment period (Wilde Mathews, 6/13).

The Associated Press: Aetna Buys Genworth Financial Business For $290 Million
Aetna Inc. said Monday it will buy the Medicare supplement business of Genworth Financial Inc. for about $290 million, as it becomes the latest health insurer to announce a plan that capitalizes on the aging baby boomer population (Murphy, 6/13).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
KFF Health News' 'What the Health?': Biden wins early court test for Medicare drug negotiations